2 Methods Due to the lack of studies evaluating the connection between GLP-1 agonists and acne, Ogunremi et al performed a web-based meta-analysis on 6 GLP-1 agonists using PubMed
However, the superior efficacy of tirzepatide across multiple endpoints and patient populations suggests that multi-pathway approaches will increasingly become the standard of care for metabolic diseases
GuoFDaiQZengXLiuYTanZZhangHet al
Identifying Ideal Candidates for Semaglutide The semaglutide weight loss program at Klinic is ideal for individuals with a BMI of 30 or higher, or a BMI of 27 or higher coupled with weight-related health conditions like high blood pressure, type 2 diabetes, or elevated cholesterol
985-P: Oral semaglutide as add-on to insulin in T2D: PIONEER 8
Clinical studies have demonstrated significant weight loss in patients using these medications, making them a viable option for those struggling with obesity